CHAT and Alzheimer disease: Reductions in CRF immunoreactivity in the cerebral cortex have been correlated with lower levels of choline acetyltransferase (ChAT) activity, which impacts the biosynthesis of acetylcholine and hence may be an important contributor to the cholinergic loss observed in AD [35].